作者: Gyan P Mishra , Viral Tamboli , Jwala Jwala , Ashim K Mitra , None
DOI: 10.2174/187221311794474883
关键词:
摘要: Ocular allergy is an inflammatory response of the conjunctival mucosa that also affects cornea and eyelids. Allergic conjunctivitis includes seasonal allergic (SAC), perennial (PAC), vernal keratoconjunctivitis (VKC), atopic (AKC) giant papillary (GPC). In general, conditions involve mast cell degranulation leads to release mediators activation enzymatic cascades generating pro-inflammatory mediators. chronic ocular disorders associated with such as VKC AKC constant observed due predominance eosinophils Th2-generated cytokines. Antihistamines, mast-cell stabilizers, nonsteroidal anti-inflammatory agents, corticosteroids immunomodulatory agents are commonly indicated for treatment acute conjunctivitis. recent years newer drug molecules have been introduced in This article reviews patents emerging therapeutics